X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11393) 11393
Publication (946) 946
Newspaper Article (794) 794
Newsletter (357) 357
Book Review (159) 159
Book Chapter (142) 142
Magazine Article (53) 53
Trade Publication Article (35) 35
Government Document (30) 30
Conference Proceeding (15) 15
Web Resource (12) 12
Dissertation (9) 9
Reference (8) 8
Book / eBook (6) 6
Transcript (6) 6
Data Set (3) 3
Paper (2) 2
Streaming Video (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8015) 8015
pneumonia (7987) 7987
index medicus (6759) 6759
female (4528) 4528
male (4385) 4385
mortality (3316) 3316
adult (2691) 2691
infections (2671) 2671
bacterial pneumonia (2650) 2650
infectious diseases (2623) 2623
middle aged (2564) 2564
aged (2112) 2112
health aspects (2104) 2104
influenza (1972) 1972
risk factors (1959) 1959
animals (1703) 1703
children (1698) 1698
immunology (1624) 1624
viruses (1624) 1624
infant (1594) 1594
research (1586) 1586
child, preschool (1564) 1564
child (1552) 1552
infection (1493) 1493
diagnosis (1480) 1480
community-acquired pneumonia (1479) 1479
respiratory system (1477) 1477
adolescent (1442) 1442
epidemiology (1400) 1400
disease (1324) 1324
pediatrics (1240) 1240
patients (1168) 1168
medicine (1136) 1136
hospitals (1130) 1130
microbiology (1123) 1123
antibiotics (1120) 1120
care and treatment (1110) 1110
pandemics (1102) 1102
vaccines (1096) 1096
retrospective studies (1073) 1073
analysis (1064) 1064
research article (1049) 1049
medical research (911) 911
aged, 80 and over (856) 856
hospitalization (853) 853
mice (849) 849
young adult (844) 844
studies (838) 838
bacterial infections (831) 831
coronaviruses (824) 824
viral infections (820) 820
prospective studies (814) 814
respiratory tract diseases (804) 804
bacteria (803) 803
pathogens (795) 795
medicine, general & internal (791) 791
adults (775) 775
public health (743) 743
epidemics (741) 741
anti-bacterial agents - therapeutic use (739) 739
treatment outcome (737) 737
inflammation (733) 733
infant, newborn (731) 731
respiratory diseases (719) 719
multidisciplinary sciences (702) 702
virology (687) 687
streptococcus infections (674) 674
lung diseases (672) 672
incidence (666) 666
science (661) 661
sepsis (661) 661
age (657) 657
medicine & public health (657) 657
medicine, experimental (653) 653
respiratory syncytial virus (648) 648
prognosis (642) 642
vaccination (640) 640
covid-19 (631) 631
transplantation (631) 631
internal medicine (617) 617
virus diseases (615) 615
pneumonia, viral - epidemiology (608) 608
lungs (604) 604
risk-factors (602) 602
management (601) 601
prevention (588) 588
laboratories (584) 584
morbidity (575) 575
abridged index medicus (573) 573
influenza, human - epidemiology (572) 572
critical care medicine (565) 565
immunization (551) 551
etiology (547) 547
hiv (541) 541
polymerase chain reaction (534) 534
severity of illness index (526) 526
streptococcus-pneumoniae (510) 510
development and progression (501) 501
infants (501) 501
lung - pathology (495) 495
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12426) 12426
French (65) 65
Spanish (65) 65
German (59) 59
Japanese (31) 31
Russian (29) 29
Chinese (21) 21
Korean (15) 15
Turkish (14) 14
Dutch (9) 9
Portuguese (9) 9
Italian (7) 7
Hungarian (5) 5
Croatian (2) 2
Persian (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Danish (1) 1
Latvian (1) 1
Lithuanian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9773, pp. 1264 - 1275
Summary About 200 million cases of viral community-acquired pneumonia occur every year—100 million in children and 100 million in adults. Molecular diagnostic... 
Internal Medicine | ETIOLOGIC DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | COMMUNITY-ACQUIRED PNEUMONIA | POLYMERASE-CHAIN-REACTION | HUMAN METAPNEUMOVIRUS INFECTION | REQUIRING HOSPITALIZATION | PANDEMIC INFLUENZA | STAPHYLOCOCCUS-AUREUS | SYNCYTIAL VIRUS | INFLUENZA A(H1N1) INFECTION | RESPIRATORY-TRACT INFECTIONS | Community-Acquired Infections - diagnosis | United States - epidemiology | Age Distribution | Pandemics | Age Factors | Community-Acquired Infections - epidemiology | Developing Countries - statistics & numerical data | Humans | Pneumonia, Viral - drug therapy | Lung - diagnostic imaging | Pneumonia, Bacterial - prevention & control | Specimen Handling | Lung - virology | Pneumonia, Viral - epidemiology | Adult | Immunocompetence | Child | Community-Acquired Infections - virology | Diagnosis, Differential | Lung - pathology | Pneumonia, Bacterial - microbiology | Global Health | Antiviral Agents - therapeutic use | Comorbidity | Pneumonia, Bacterial - epidemiology | Biomarkers - blood | Pneumonia, Bacterial - diagnosis | Radiography | Pneumonia, Viral - prevention & control | Pneumonia, Viral - diagnosis | Pneumonia, Viral - mortality | Pneumonia, Viral - virology | Causes of | Viral pneumonia | Care and treatment | Diagnosis | Pneumonia | Pathogenesis | Mortality | Severe acute respiratory syndrome | Industrialized nations | Viruses | Infections | Epidemiology | Avian flu | Developing countries--LDCs | Swine flu | Viral infections
Journal Article
Gut, ISSN 0017-5749, 02/2017, Volume 66, Issue 2, pp. 330 - 341
Journal Article
The Lancet, ISSN 0140-6736, 10/2004, Volume 364, Issue 9443, pp. 1428 - 1434
Prophylaxis with co-trimoxazole (trimethoprim-sulphamethoxazole) is recommended for people with HIV infection or AIDS but is rarely used in Africa. We assessed... 
BACTERIAL PNEUMONIA | MEDICINE, GENERAL & INTERNAL | PNEUMOCYSTIS-CARINII-PNEUMONIA | COTE-DIVOIRE | PLASMODIUM-FALCIPARUM | IMMUNE ACTIVATION | RANDOMIZED-TRIAL | OPPORTUNISTIC INFECTIONS | TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS | HIV-1-INFECTED ADULTS | IMMUNODEFICIENCY-VIRUS DISEASE | HIV-1 | Humans | Uganda - epidemiology | Diarrhea - prevention & control | Male | Antibiotic Prophylaxis | Viral Load | HIV Infections - immunology | Adult | Female | HIV Infections - mortality | Child | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | HIV Infections - virology | CD4 Lymphocyte Count | Hospitalization | Ambulatory Care | Malaria - prevention & control | Drug Resistance, Microbial | AIDS-Related Opportunistic Infections - prevention & control | Anti-Infective Agents - administration & dosage | Antimalarials - administration & dosage | Adolescent | HIV Infections - complications | Malaria - complications | Antiviral agents | AIDS patients | Co-trimoxazole | Dosage and administration | Research | Drug therapy | HIV infection | Drug resistance in microorganisms | Usage | Health aspects | Clinical trials | Rural areas | Mortality | Human immunodeficiency virus--HIV | Morbidity | Vector-borne diseases | Load distribution | Malaria | Households | Prophylaxis | Diarrhea | Trimethoprim | Antimicrobial agents | Infections | Drug resistance | Fever | CD4 antigen | Studies | Acquired immune deficiency syndrome--AIDS | Consent | Counseling | Guardians | Medical tests
Journal Article
Medicine, ISSN 0025-7974, 09/2006, Volume 85, Issue 5, pp. 278 - 287
Community respiratory viruses (CRVs) have been recognized as a potential cause of pneumonia and death among hematopoietic stem cell transplantation (HSCT)... 
MEDICINE, GENERAL & INTERNAL | INFLUENZA-C VIRUSES | SYNCYTIAL VIRUS-INFECTION | RISK-FACTORS | NEURAMINIDASE INHIBITOR OSELTAMIVIR | ANTIVIRAL THERAPY | BONE-MARROW-TRANSPLANTATION | PEDIATRIC-PATIENTS | PARAINFLUENZA VIRUS | IMMUNOCOMPROMISED ADULTS | CLINICAL-FEATURES | Multivariate Analysis | Respiratory Syncytial Virus Infections - mortality | United States - epidemiology | Virus Diseases - epidemiology | Humans | Middle Aged | Pneumonia, Viral - etiology | Respiratory Tract Infections - prevention & control | Male | Respiratory Tract Infections - mortality | Pneumonia, Viral - epidemiology | Respiratory Syncytial Virus Infections - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Respiratory Syncytial Virus Infections - prevention & control | Influenza, Human - mortality | Adult | Female | Influenza, Human - virology | Retrospective Studies | Respiratory Tract Infections - virology | Community-Acquired Infections - virology | Paramyxoviridae Infections - etiology | Hematologic Neoplasms - virology | Risk Factors | Logistic Models | Influenza, Human - etiology | Paramyxoviridae Infections - mortality | Virus Diseases - etiology | Pneumonia, Viral - prevention & control | Adolescent | Aged | Pneumonia, Viral - mortality | Virus Diseases - mortality | Immunocompromised Host | Paramyxoviridae Infections - prevention & control | Respiratory Tract Infections - epidemiology | Influenza, Human - prevention & control | Pneumonia, Viral - virology | Virus Diseases - prevention & control | Respiratory tract infections | Prevention | Viral pneumonia | Causes of | Transplantation | Drug therapy | Health aspects | Hematopoietic stem cells
Journal Article
Scientific Reports, ISSN 2045-2322, 05/2016, Volume 6, Issue 1, p. 25359
Journal Article
Journal Article